Richard Whelton leads strategy and marketing at Congruence Medical Solutions. He has two decades of experience in medical technology, devices and life sciences, and is passionate about improving human health through innovative solutions. Over his career, he has held multiple roles in strategy, innovation and marketing, including a decade at Becton Dickinson & Co, where he developed and commercialised a variety of drug delivery products, including self-injection and infusion devices. Mr Whelton holds an MBA from The Wharton School at the University of Pennsylvania (US) and a Master’s degree in Biochemistry from the University of Oxford (UK).
Richard Whelton introduces the new Congruence Autoinjector, a next-generation disposable autoinjector platform, which leverages a compressed-gas power source and has significant advantages over currently available legacy devices, including the ability to deliver higher viscosity and larger volume drugs, easier customisation and enhanced usability that addresses well-known user errors.